Venkat Pharma Ltd

Venkat Pharma Ltd

₹ 3.40 -4.76%
18 May 2015
About

Venkat Pharma Ltd is engaged in the manufacture and sale of finished dosages of pharmaceutical products in India.

  • Market Cap Cr.
  • Current Price 3.40
  • High / Low /
  • Stock P/E
  • Book Value 10.0
  • Dividend Yield 0.00 %
  • ROCE -0.30 %
  • ROE %
  • Face Value 10.0

Pros

  • Stock is trading at 0.34 times its book value

Cons

  • Company has low interest coverage ratio.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.01 0.00 0.01 0.00 0.00 0.01 0.01 0.00
Operating Profit -0.01 0.00 -0.01 0.00 0.00 -0.01 -0.01 0.00
OPM %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax -0.01 0.00 -0.01 0.00 0.00 -0.01 -0.01 0.00
Tax % 0.00% 0.00% 0.00% 0.00%
-0.01 0.00 -0.01 -0.01 0.00 -0.01 -0.01 0.00
EPS in Rs -0.02 0.00 -0.02 -0.02 0.00 -0.02 -0.02 0.00
Raw PDF

Profit & Loss

Figures in Rs. Crores

Jun 2006 15m Mar 2007 9m Mar 2008 Mar 2010 Mar 2011 Mar 2012 Mar 2013 TTM
13.84 0.63 1.05 0.00 0.00 0.00 0.00 0.00
12.56 6.92 2.39 0.20 0.04 0.02 0.03 0.02
Operating Profit 1.28 -6.29 -1.34 -0.20 -0.04 -0.02 -0.03 -0.02
OPM % 9.25% -998.41% -127.62%
0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Interest 2.03 0.25 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.28 0.13 0.06 0.04 0.02 0.02 0.02 0.00
Profit before tax -1.03 -6.67 -1.39 -0.24 -0.06 -0.04 -0.05 -0.02
Tax % -5.83% 0.15% 0.00% 4.17% 0.00% 0.00% 0.00%
-0.97 -6.68 -1.39 -0.25 -0.06 -0.04 -0.04 -0.02
EPS in Rs -1.94 -13.39 -2.79 -0.50 -0.12 -0.08 -0.08 -0.04
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: 15%
3 Years: 23%
TTM: 33%
Stock Price CAGR
10 Years: 0%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Jun 2006 Mar 2007 Mar 2008 Mar 2010 Mar 2011 Mar 2012 Mar 2013
Equity Capital 4.99 4.99 4.99 4.99 4.99 4.99 4.99
Reserves 1.40 -5.28 -6.67 -7.38 -7.44 -7.48 -7.53
15.63 16.20 16.19 16.19 16.19 19.20 19.22
7.66 4.48 4.67 4.47 4.39 1.42 1.31
Total Liabilities 29.68 20.39 19.18 18.27 18.13 18.13 17.99
1.21 1.08 1.00 0.92 0.89 0.87 0.85
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
28.47 19.31 18.18 17.35 17.24 17.26 17.14
Total Assets 29.68 20.39 19.18 18.27 18.13 18.13 17.99

Cash Flows

Figures in Rs. Crores

Jun 2006 Mar 2007 Mar 2008 Mar 2010 Mar 2011 Mar 2012 Mar 2013
0.00 0.00 -0.01 0.00
0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00
Net Cash Flow 0.00 0.00 -0.01 0.00

Ratios

Figures in Rs. Crores

Jun 2006 Mar 2007 Mar 2008 Mar 2010 Mar 2011 Mar 2012 Mar 2013
Debtor Days 482.89 8,632.54 4,599.00
Inventory Days 181.06 394.02 890.44
Days Payable 182.29 652.11 1,776.87
Cash Conversion Cycle 481.65 8,374.44 3,712.57
Working Capital Days 539.59 8,487.70 4,672.00
ROCE % -9.14% -0.44% -0.26% -0.30%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports

No data available.